Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$12.93 - $18.45 $881,826 - $1.26 Million
68,200 New
68,200 $984,000
Q1 2023

May 12, 2023

BUY
$8.79 - $14.58 $1.45 Million - $2.41 Million
165,000 Added 366.67%
210,000 $1.97 Million
Q4 2022

Feb 08, 2023

SELL
$11.49 - $13.65 $459,600 - $546,000
-40,000 Reduced 47.06%
45,000 $549,000
Q3 2022

Nov 10, 2022

BUY
$12.41 - $32.42 $1.05 Million - $2.76 Million
85,000 New
85,000 $1.06 Million
Q1 2022

May 16, 2022

BUY
$24.65 - $29.0 $1.23 Million - $1.45 Million
50,000 Added 100.0%
100,000 $2.61 Million
Q2 2021

Aug 13, 2021

SELL
$28.76 - $35.98 $2.88 Million - $3.6 Million
-100,000 Reduced 66.67%
50,000 $1.74 Million
Q1 2021

May 12, 2021

BUY
$27.85 - $34.49 $2.79 Million - $3.45 Million
100,000 Added 200.0%
150,000 $4.42 Million
Q4 2020

Feb 11, 2021

BUY
$27.53 - $33.79 $1.38 Million - $1.69 Million
50,000 New
50,000 $1.53 Million

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $5.42B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.